Midgard Science

Suppliers / Compounds & building blocks

Dark Blue Therapeutics

Oxford, United Kingdom · darkbluetx.com

Dark Blue Therapeutics develops precision oncology medicines focused on novel cancer dependencies and vulnerabilities. It works with academic partners and internal discovery science to advance small-molecule programs for biomarker-selected patient populations. The company is based in Oxford, United Kingdom.

They take quote requests by email.

What they offer

  • Target validation

    Uses functional genomics and informatics-based approaches to identify and validate cancer targets with high transformative potential.

  • Hit discovery

    Discovers starting points for drug programs against selected cancer targets using proprietary data and structural insights.

  • Hit validation

    Evaluates discovered hits to support progression into lead-generation stages.

  • Hit-to-lead optimization

    Optimizes hits into more developed chemical matter using cutting-edge discovery science and medicinal chemistry.

  • Lead optimization

    Refines lead compounds to improve efficacy and mechanism fit for the selected target.

  • IND-enabling studies

    Advances programs through IND-enabling work for clinical development.

What they work on

Services
Small molecule, Antibody
Sites
Oxford, United Kingdom

Similar suppliers. 2bind Pharma Services, AAPharmaSyn, Aberjona Laboratories, Acellera

Found in a contract services directory. Listing built from darkbluetx.com. Work here? Claim this listing.

Dark Blue Therapeutics · Midgard Science